Candel Therapeutics (CADL) Non Operating Interest Expenses (2022 - 2026)
Candel Therapeutics' Non Operating Interest Expenses was $1.58 million in Q2 2026, up 567.4% from $236,000 a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Candel Therapeutics' Non Operating Interest Expenses was $3.39 million through Jun 30, 2026, up 138.8% year-over-year; for FY2025, it was $2.12 million, up 1.4% from FY2024.
- Non Operating Interest Expenses shows a three-year compound annual growth rate of 7.5% (FY2022 to FY2025).
- In earlier years, Non Operating Interest Expenses was $2.09 million in FY2024 (-19.5%), $2.6 million in FY2023 (+51.9%) and $1.71 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses in data going back to Q2 2022.
- Compared with a year earlier, Non Operating Interest Expenses was higher in two of the last seven quarters, with growth averaging 83.3%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2026 (growth of 567.4%); the worst was Q3 2025 (a decline of 66.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Candel Therapeutics | 773.36 Mn | 773.36 Mn | - | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 236,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | 487,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 646,000.00 |
| Dec 31, 2023 | 673,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Jun 30, 2023 | 644,000.00 |
| Mar 31, 2023 | 609,000.00 |
| Dec 31, 2022 | 578,000.00 |
| Sep 30, 2022 | 519,000.00 |
| Jun 30, 2022 | 435,000.00 |
API Access
Candel Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();